Literature DB >> 24901451

Antenatal magnesium sulfate and spontaneous intestinal perforation in infants less than 25 weeks gestation.

B N Rattray1, D M Kraus2, L R Drinker1, R N Goldberg1, D T Tanaka1, C M Cotten1.   

Abstract

OBJECTIVE: Evaluate spontaneous intestinal perforation (SIP)/death among extremely low birthweight (ELBW) infants before, during and after initiation of an antenatal magnesium for neuroprotection protocol (MgPro). STUDY
DESIGN: We tested associations between SIP/death and magnesium exposure, gestational age (GA) and interactions with GA and magnesium exposure in a cohort of inborn ELBW infants before, during and after MgPro. RESULT: One hundred and fifty-five ELBW infants were included, 81 before, 23 during and 51 after MgPro. ELBW infants (78.3%) were exposed to Mg during MgPro compared with 50.6% and 60.8% before and after, respectively. Incidence of SIP on protocol was 30.4% vs 12.9% off protocol (P=0.03). GA was strongly associated with SIP (P<0.01). Antenatal Mg dose was also associated with SIP/death regardless of epoch (odds ratio 9.3 (1.04-104.6)), but increased SIP/death was limited to those <25 weeks gestation.
CONCLUSION: Higher Mg dose was associated with higher SIP and death risk among infants with the lowest birthweights. Validation of this observation in larger populations is warranted.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24901451     DOI: 10.1038/jp.2014.106

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  23 in total

1.  Effects of antenatal magnesium sulfate therapy on cerebral and systemic hemodynamics in preterm newborns.

Authors:  Mahmoud Shokry; Ghada O Elsedfy; Mohamed M Bassiouny; Mohamed Anmin; Hosam Abozid
Journal:  Acta Obstet Gynecol Scand       Date:  2010-06       Impact factor: 3.636

2.  Magnesium sulfate tocolysis: time to quit.

Authors:  Robert Mittendorf
Journal:  Obstet Gynecol       Date:  2007-05       Impact factor: 7.661

3.  Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia.

Authors:  J K Grether; J Hoogstrate; E Walsh-Greene; K B Nelson
Journal:  Am J Obstet Gynecol       Date:  2000-09       Impact factor: 8.661

4.  Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1,750 grams.

Authors:  C A Boyle; M Yeargin-Allsopp; D E Schendel; P Holmgreen; G P Oakley
Journal:  Am J Epidemiol       Date:  2000-07-15       Impact factor: 4.897

5.  Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial.

Authors:  Kristi L Watterberg; Jeffrey S Gerdes; Cynthia H Cole; Susan W Aucott; Elizabeth H Thilo; Mark C Mammel; Robert J Couser; Jeffery S Garland; Henry J Rozycki; Corinne L Leach; Conra Backstrom; Michele L Shaffer
Journal:  Pediatrics       Date:  2004-12       Impact factor: 7.124

6.  Effects of magnesium on prostacyclin synthesis and intracellular free calcium concentration in vascular cells.

Authors:  Kazuo Satake; Jong-Dae Lee; Hiromasa Shimizu; Hiroyasu Uzui; Yasuhiko Mitsuke; Hong Yue; Takanori Ueda
Journal:  Magnes Res       Date:  2004-03       Impact factor: 1.115

Review 7.  Understanding intestinal vulnerability to perforation in the extremely low birth weight infant.

Authors:  Phillip V Gordon
Journal:  Pediatr Res       Date:  2009-02       Impact factor: 3.756

8.  Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?

Authors:  K B Nelson; J K Grether
Journal:  Pediatrics       Date:  1995-02       Impact factor: 7.124

9.  A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.

Authors:  Dwight J Rouse; Deborah G Hirtz; Elizabeth Thom; Michael W Varner; Catherine Y Spong; Brian M Mercer; Jay D Iams; Ronald J Wapner; Yoram Sorokin; James M Alexander; Margaret Harper; John M Thorp; Susan M Ramin; Fergal D Malone; Marshall Carpenter; Menachem Miodovnik; Atef Moawad; Mary J O'Sullivan; Alan M Peaceman; Gary D V Hankins; Oded Langer; Steve N Caritis; James M Roberts
Journal:  N Engl J Med       Date:  2008-08-28       Impact factor: 91.245

10.  Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants.

Authors:  Robert Mittendorf; James Dambrosia; Peter G Pryde; Kwang-Sun Lee; John G Gianopoulos; Richard E Besinger; Paul G Tomich
Journal:  Am J Obstet Gynecol       Date:  2002-06       Impact factor: 8.661

View more
  11 in total

1.  Lack of Evidence for Time or Dose Relationship between Antenatal Magnesium Sulfate and Intestinal Injury in Extremely Preterm Neonates.

Authors:  Michel Mikhael; Cheryl Bronson; Lishi Zhang; Mark Curran; Helen Rodriguez; Kushal Y Bhakta
Journal:  Neonatology       Date:  2019-04-09       Impact factor: 4.035

2.  Magnesium induces preconditioning of the neonatal brain via profound mitochondrial protection.

Authors:  Gabriella Koning; Anna-Lena Leverin; Syam Nair; Leslie Schwendimann; Joakim Ek; Ylva Carlsson; Pierre Gressens; Claire Thornton; Xiaoyang Wang; Carina Mallard; Henrik Hagberg
Journal:  J Cereb Blood Flow Metab       Date:  2017-12-05       Impact factor: 6.200

3.  Increased Risk of Meconium-Related Ileus in Extremely Premature Infants Exposed to Antenatal Magnesium Sulfate.

Authors:  Se In Sung; So Yoon Ahn; Suk-Joo Choi; Soo-Young Oh; Cheong-Rae Roh; Misun Yang; Yun Sil Chang; Won Soon Park
Journal:  Neonatology       Date:  2022-01-11       Impact factor: 4.035

4.  Antenatal Magnesium Sulfate for Preterm Neuroprotection: A Single-Center Experience from Kuwait Tertiary NICU.

Authors:  Mariam Ayed; Javed Ahmed; Kiran More; Amal Ayed; Hamid Husain; Ammar AlQurashi; Najla Alrajaan
Journal:  Biomed Hub       Date:  2022-06-30

5.  Antenatal Magnesium Sulfate, Necrotizing Enterocolitis, and Death among Neonates < 28 Weeks Gestation.

Authors:  Manijeh Kamyar; Erin A S Clark; Bradley A Yoder; Michael W Varner; Tracy A Manuck
Journal:  AJP Rep       Date:  2016-03

6.  Impact of umbilical cord milking and pasteurized donor human milk on necrotizing enterocolitis: a retrospective review.

Authors:  Mehtab K Sekhon; Bradley A Yoder
Journal:  BMC Pediatr       Date:  2018-05-08       Impact factor: 2.125

Review 7.  Magnesium sulfate and fetal neuroprotection: overview of clinical evidence.

Authors:  Clément Chollat; Stéphane Marret
Journal:  Neural Regen Res       Date:  2018-12       Impact factor: 5.135

8.  Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis.

Authors:  Emily Shepherd; Rehana A Salam; Deepak Manhas; Anne Synnes; Philippa Middleton; Maria Makrides; Caroline A Crowther
Journal:  PLoS Med       Date:  2019-12-06       Impact factor: 11.069

9.  Association of in utero magnesium exposure and spontaneous intestinal perforations in extremely low birth weight infants.

Authors:  L C Downey; C M Cotten; C P Hornik; M M Laughon; V N Tolia; R H Clark; P B Smith
Journal:  J Perinatol       Date:  2017-01-26       Impact factor: 3.225

10.  Antenatal magnesium sulfate treatment and risk of necrotizing enterocolitis in preterm infants born at less than 32 weeks of gestation.

Authors:  Ji Young Hong; Jee Youn Hong; Yun-Sun Choi; Yoo-Min Kim; Ji-Hee Sung; Suk-Joo Choi; Soo-Young Oh; Cheong-Rae Roh; Hye Seon Kim; Se In Sung; So Yoon Ahn; Yun Sil Chang; Won Soon Park
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.